Clinical Trials List
Protocol NumberMOZ11809
2010-07-01 - 2012-06-30
Phase IV
Terminated2
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Jyh-Pyng Gau Division of Hematology & Oncology
- 蕭梁材 Division of Hematology & Oncology
- Jin-Hwang Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林建廷 Division of Hematology & Oncology
- Shang-Yi Huang Division of Hematology & Oncology
- 李啟誠 Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- - - Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
70 participants
